Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.067 | 0.7 |